Considering a biochemical therapeutic viewpoint, Relafen 750 (Naproxen Sodium) showcases a significant illustration of noncopyrightal anti-inflammatory agent. Its mechanism revolves around suppressing cyclooxygenase proteins, specifically COX-1 and COX-2, thereby lessening the synthesis of prostagla